Study of the Safety of Therapeutic Tx With Immunomodulatory MSC in Adults With COVID-19 Infection Requiring Mechanical Ventilation
Clinical trial NCT04397796 · TERMINATED
Trial details
- NCT number
- NCT04397796
- Sponsor
- ImmunityBio, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-03
- Primary completion
- 2020-09-06
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.